tradingkey.logo

Elanco Animal Health Inc

ELAN
查看詳細走勢圖
22.305USD
+0.215+0.97%
收盤 12/19, 16:00美東報價延遲15分鐘
11.08B總市值
308.38本益比TTM

Elanco Animal Health Inc

22.305
+0.215+0.97%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.97%

5天

+4.77%

1月

+5.01%

6月

+65.71%

今年開始到現在

+84.19%

1年

+91.79%

查看詳細走勢圖

TradingKey Elanco Animal Health Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Elanco Animal Health Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名24/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價25.15。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Elanco Animal Health Inc評分

相關信息

行業排名
24 / 158
全市場排名
74 / 4582
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 16 分析師
買入
評級
25.154
目標均價
+15.97%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Elanco Animal Health Inc亮點

亮點風險
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值308.31,處於3年歷史高位
機構加倉
最新機構持股577.24M股,環比增加0.01%
查克·羅伊斯持倉
明星投資者查克·羅伊斯持倉,最新持倉602.56K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.06

Elanco Animal Health Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Elanco Animal Health Inc簡介

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
公司代碼ELAN
公司Elanco Animal Health Inc
CEOSimmons (Jeffrey N)
網址https://www.elanco.com/

常見問題

Elanco Animal Health Inc(ELAN)的當前股價是多少?

Elanco Animal Health Inc(ELAN)的當前股價是 22.305。

Elanco Animal Health Inc 的股票代碼是什麼?

Elanco Animal Health Inc的股票代碼是ELAN。

Elanco Animal Health Inc股票的52週最高點是多少?

Elanco Animal Health Inc股票的52週最高點是23.700。

Elanco Animal Health Inc股票的52週最低點是多少?

Elanco Animal Health Inc股票的52週最低點是8.020。

Elanco Animal Health Inc的市值是多少?

Elanco Animal Health Inc的市值是11.08B。

Elanco Animal Health Inc的淨利潤是多少?

Elanco Animal Health Inc的淨利潤為338.00M。

現在Elanco Animal Health Inc(ELAN)的股票是買入、持有還是賣出?

根據分析師評級,Elanco Animal Health Inc(ELAN)的總體評級為買入,目標價格為25.154。

Elanco Animal Health Inc(ELAN)股票的每股收益(EPS TTM)是多少

Elanco Animal Health Inc(ELAN)股票的每股收益(EPS TTM)是0.072。
KeyAI